Clinical Trials for Leukemia, Lymphocytic, Chronic, B-Cell

A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

NCT ID: NCT06788509

Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT06364423

This clinical trial is studying a new treatment called anti-CD19 CAR T-cell therapy for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), which are types of blood ...

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

NCT ID: NCT05947851

This clinical trial is investigating a new treatment for patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The study is comparing two trea...

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

NCT ID: NCT03331198

This clinical trial is looking at a new treatment called JCAR017 for adults with relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL). The goal is to see ho...

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

NCT ID: NCT05963074

This clinical trial is investigating how effective and safe a combination treatment of ibrutinib and venetoclax is, compared to using ibrutinib alone, for patients with chronic lymphocytic leukemia...

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia

NCT ID: NCT06299540

This clinical trial is studying how a personalized physical activity program can improve the quality of life for people with chronic lymphocytic leukemia (CLL) who are starting treatment with a med...

A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT05424822

This clinical trial is studying a new treatment called JNJ-80948543, which is an experimental antibody designed to help the immune system target specific types of blood cancers, including non-Hodgk...

Zanubrutinib and Venetoclax as Initial Therapy for Chronic Lymphocytic Leukemia (CLL) With Response-based Obinutuzumab

NCT ID: NCT05650723

This clinical trial is studying a new way to treat patients with chronic lymphocytic leukemia (CLL) using two oral medications, zanubrutinib and venetoclax. The researchers believe that instead of ...

Family Study of Lymphoproliferative Disorders

NCT ID: NCT00626496

**Summary of the Family Study of Lymphoproliferative Disorders** This clinical trial is focused on understanding blood and lymph node cancers, including different types of lymphoma and leukemia. T...

Institut Paoli Calmettes Chronic Lymphatic Leukemia Database

NCT ID: NCT02869529

The Institut Paoli Calmettes is conducting a clinical trial to create a database for patients diagnosed with chronic lymphatic leukemia, specifically the B-cell type. This study aims to gather impo...